Sinil Pharmaceutical Co Ltd
KOSDAQ:012790
Wall Street
Price Targets
Price Targets Summary
Sinil Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Sinil Pharmaceutical Co Ltd is 20 300 KRW .
Operating Income
Forecast
Operating Income Estimate
Sinil Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Sinil Pharmaceutical Co Ltd's operating income is 4%. The projected CAGR for the next 7 years is -3%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Sinil Pharmaceutical Co Ltd's stock price target?
Price Target
20 300
KRW
According to Wall Street analysts, the average 1-year price target for Sinil Pharmaceutical Co Ltd is 20 300 KRW .
What is Sinil Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
-8%
For the last 8 years the compound annual growth rate for Sinil Pharmaceutical Co Ltd's revenue is 9%. The projected CAGR for the next 7 years is -8%.
What is Sinil Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-3%
For the last 8 years the compound annual growth rate for Sinil Pharmaceutical Co Ltd's operating income is 4%. The projected CAGR for the next 7 years is -3%.
What is Sinil Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-4%
For the last 8 years the compound annual growth rate for Sinil Pharmaceutical Co Ltd's net income is 6%. The projected CAGR for the next 7 years is -4%.